
Novo's Wegovy Pill Reaches 1 Million Patients, but Competitive Heat Weighs on Shares
As Eli Lilly surges and Amazon Pharmacy enters the fray, Novo Nordisk fights back with global expansion and deep cost cuts.

As Eli Lilly surges and Amazon Pharmacy enters the fray, Novo Nordisk fights back with global expansion and deep cost cuts.

University of Pennsylvania researchers develop a gum that targets oral microbes linked to cancer while sparing beneficial bacteria; clinical trials are next.

New research reveals the brain's biological memory for fat, explaining rapid weight regain after stopping weight-loss drugs like Wegovy and Mounjaro.

From TAOK-1 proteins to brain fat, CBD, and lithium, scientists are rethinking Alzheimer's disease and its treatment.

After years of one-way data flow and third-party workarounds, Google's rebranded Fitbit app now shares workouts, steps, and vitals directly with Apple Health — a win for cross-platform wellness tracking.

From EPA climate finding repeal to DOJ backing xAI, the administration’s pollution agenda faces courtroom challenges.

LED headlights are brighter than ever, prompting driver complaints, safety warnings, and calls for new regulations on both sides of the Atlantic.

From cancer vaccines to skincare, peptides are booming—yet experts warn of risky, unproven products flooding shelves.
As Johnson & Johnson's Ottava gains FDA clearance and humanoid robots perform live surgery, the operating room is being transformed globally by robotics and AI.

New research from Canada reveals why statins cause muscle aches in some people, while placebo trials show many symptoms are psychological.